Phase IB/II study of lirilumab with azacytidine (AZA) in relapsed AML.
Year: 2017
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Naval Guastad Daver, Guillermo Garcia-Manero, Jorge E. Cortes, Sreyashi Basu, Farhad Ravandi, Tapan M. Kadia, Gautam Borthakur, Elias Jabbour, Courtney Denton Dinardo, Naveen Pemmaraju, Mark Brandt, Sherry Pierce, Nawar Hussin, Steven Mitchell Kornblau, Michael Andreeff, Marina Konopleva, Jing Ning, James Patrick Allison, Padmanee Sharma, Hagop M. Kantarjian
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2890113688